Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

USA - NASDAQ:MHUA - KYG5966G1082 - Common Stock

0.3703 USD
-0.02 (-4.46%)
Last: 10/16/2025, 10:53:04 AM
Fundamental Rating

5

Overall MHUA gets a fundamental rating of 5 out of 10. We evaluated MHUA against 191 industry peers in the Health Care Equipment & Supplies industry. While MHUA has a great health rating, its profitability is only average at the moment. MHUA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MHUA had positive earnings in the past year.
In the past year MHUA had a positive cash flow from operations.
MHUA had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

MHUA's Return On Assets of 7.34% is amongst the best of the industry. MHUA outperforms 90.58% of its industry peers.
With an excellent Return On Equity value of 8.48%, MHUA belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
The Return On Invested Capital of MHUA (7.79%) is better than 85.34% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MHUA is below the industry average of 8.89%.
The 3 year average ROIC (6.66%) for MHUA is below the current ROIC(7.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROIC 7.79%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

MHUA has a Profit Margin of 10.37%. This is amongst the best in the industry. MHUA outperforms 83.25% of its industry peers.
MHUA's Profit Margin has declined in the last couple of years.
MHUA has a Operating Margin of 13.01%. This is amongst the best in the industry. MHUA outperforms 80.63% of its industry peers.
In the last couple of years the Operating Margin of MHUA has declined.
Looking at the Gross Margin, with a value of 34.04%, MHUA is doing worse than 73.30% of the companies in the same industry.
MHUA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
MHUA has more shares outstanding than it did 1 year ago.
MHUA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MHUA has about the same debt to assets ratio.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

MHUA has an Altman-Z score of 2.98. This is not the best score and indicates that MHUA is in the grey zone with still only limited risk for bankruptcy at the moment.
MHUA has a better Altman-Z score (2.98) than 68.06% of its industry peers.
The Debt to FCF ratio of MHUA is 3.19, which is a good value as it means it would take MHUA, 3.19 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.19, MHUA belongs to the top of the industry, outperforming 86.91% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that MHUA is not too dependend on debt financing.
MHUA has a better Debt to Equity ratio (0.07) than 67.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Altman-Z 2.98
ROIC/WACC1.38
WACC5.63%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.71 indicates that MHUA has no problem at all paying its short term obligations.
The Current ratio of MHUA (5.71) is better than 82.72% of its industry peers.
MHUA has a Quick Ratio of 5.66. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA's Quick ratio of 5.66 is amongst the best of the industry. MHUA outperforms 84.82% of its industry peers.
Industry RankSector Rank
Current Ratio 5.71
Quick Ratio 5.66
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The earnings per share for MHUA have decreased strongly by -22.59% in the last year.
The earnings per share for MHUA have been decreasing by -13.75% on average. This is quite bad
MHUA shows a decrease in Revenue. In the last year, the revenue decreased by -5.30%.
The Revenue has been growing slightly by 4.01% on average over the past years.
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.76, the valuation of MHUA can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of MHUA indicates a rather cheap valuation: MHUA is cheaper than 99.48% of the companies listed in the same industry.
MHUA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.53.
Industry RankSector Rank
PE 0.76
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than MHUA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.29
EV/EBITDA -0.18
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield N/A

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (10/16/2025, 10:53:04 AM)

0.3703

-0.02 (-4.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.52%
Inst Owner Change0%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap11.81M
AnalystsN/A
Price TargetN/A
Short Float %0.39%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.76
Fwd PE N/A
P/S 0.09
P/FCF 3.29
P/OCF 3.18
P/B 0.07
P/tB 0.07
EV/EBITDA -0.18
EPS(TTM)0.49
EY132.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY30.35%
OCF(TTM)0.12
OCFY31.48%
SpS4.23
BVpS5.17
TBVpS5.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROCE 10.64%
ROIC 7.79%
ROICexc 8.54%
ROICexgc 8.57%
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
FCFM 2.66%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexcg growth 3Y-27.75%
ROICexcg growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Debt/EBITDA 0.63
Cap/Depr 24.05%
Cap/Sales 0.1%
Interest Coverage 69.48
Cash Conversion 20.54%
Profit Quality 25.63%
Current Ratio 5.71
Quick Ratio 5.66
Altman-Z 2.98
F-Score5
WACC5.63%
ROIC/WACC1.38
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.66%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%